Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5092746

CCC(NC1=NC(=Cc2c[nH]c3ncccc23)C(=O)N1)c1ccccc1.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC7 O00311 4/20 0.43
▸ CCNE1 P24864 1/20 0.43
▸ CDK2 P24941 1/20 0.43
▸ DBF4 Q9UBU7 1/20 0.43
▸ CHEK1 O14757 2/20 0.41
▸ PDE2A O00408 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.36
▸ ASPH Q12797 1/20 0.36
▸ KDM8 Q8N371 1/20 0.36
▸ CCNT1 O60563 2/20 0.36
▸ CDK9 P50750 2/20 0.36
▸ HASPIN Q8TF76 2/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ AKT1 P31749 2/20 0.36
▸ DYRK1A Q13627 3/20 0.35
▸ GSK3B P49841 1/20 0.35
▸ CHEK2 O96017 1/20 0.35
▸ CDK1 P06493 1/20 0.35
▸ SRC P12931 1/20 0.35
▸ CSNK2A2 P19784 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5092738 1.00 CDC7 (0.43) CDC7CCNE1CDK2DBF4CHEK1
SCHEMBL4791548 0.93 CDC7 (0.48) CDC7CCNE1CDK2DBF4CHEK1
SCHEMBL4791544 0.93 CDC7 (0.48) CDC7CCNE1CDK2DBF4CHEK1
Trifluoroacetic Acid SCHEMBL5089583 0.87 RPS6KB1 (0.38) CDC7CDK2CHEK1CCNT1CDK9
Trifluoroacetic Acid SCHEMBL5089597 0.87 RPS6KB1 (0.38) CDC7CDK2CHEK1CCNT1CDK9
Hydrochloric Acid SCHEMBL5089754 0.85 DYRK1A (0.46) CDC7CCNE1CDK2DBF4CHEK1
Hydrochloric Acid SCHEMBL5089745 0.85 DYRK1A (0.46) CDC7CCNE1CDK2DBF4CHEK1
Hydrochloric Acid SCHEMBL4824904 0.84 CHEK1 (0.44) CDC7CCNE1CDK2DBF4CHEK1
Hydrochloric Acid SCHEMBL5101165 0.84 CHEK1 (0.44) CDC7CCNE1CDK2DBF4CHEK1
Trifluoroacetic Acid SCHEMBL5101172 0.81 CHEK1 (0.39) CDC7CDK2CHEK1CCNT1CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7371862-B2 Azaindolylidene derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PFIZER ITALIA S.R.L. (IT) 2008-05-13 — — US claimed
US-20070112020-A1 Azaindolylidene derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PHARMACIA ITALIA S.P.A. (IT) 2007-05-17 — — US claimed
US-7371862-B2 Azaindolylidene derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PFIZER ITALIA S.R.L. (IT) 2008-05-13 — — US disclosed
US-20070112020-A1 Azaindolylidene derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PHARMACIA ITALIA S.P.A. (IT) 2007-05-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112020-A1 Azaindolylidene derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them MAP3K20, MAP3K6, MAP3K1 CDC7 128/4885CCNE1 327/4885CDK2 27/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback